Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Lymphoma, Non-Hodgkin 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myeloid, Acute 1Leukemia, Myeloid, Accelerated Phase 1Leukemia, Biphenotypic, Acute 1Hodgkin Disease 1Anemia, Refractory, with Excess of Blasts 1

Interventions

fludarabine phosphate 7Cyclophosphamide 7Whole-Body Irradiation 6Busulfan 6Mycophenolic Acid 5fludarabine 4Peripheral Blood Stem Cell Transplantation 4Melphalan 4Azacitidine 4venetoclax 3Tacrolimus 3Cyclosporine 3Biopsy 3Vorinostat 2Specimen Handling 2Rituximab 2Methotrexate 2Etoposide 2Cytarabine 2Clofarabine 2Antilymphocyte Serum 2thymoglobulin 1pegylated granulocyte colony-stimulating factor 1merphos 1ivosidenib 1decitabine and cedazuridine drug combination 1cedazuridine 1Thiotepa 1TAK-243 1Stem Cell Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Anemia, Refractory, with Excess of Blasts × Cord Blood Stem Cell Transplantation × 90 days × Clear all
NCT02727803 2026-05-22

Personalized NK Cell Therapy in CBT

M.D. Anderson Cancer Center

Phase 2 Recruiting
100 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Hodgkin Disease, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Myelodysplastic-Myeloproliferative Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡